ClinicalTrials.gov record
Completed Phase 2 Interventional

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

ClinicalTrials.gov ID: NCT00001034

Public ClinicalTrials.gov record NCT00001034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Comparative, Placebo-Controlled Trial of the Safety and Efficacy of Oral Ganciclovir for Prophylaxis of Cytomegalovirus (CMV) Retinal and Gastrointestinal Mucosal Disease in HIV-Infected Individuals With Severe Immunosuppression

Study identification

NCT ID
NCT00001034
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
850 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jul 31, 1995
Last update posted
Nov 3, 2021

Ends 1995

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Community Consortium of San Francisco San Francisco California 94110
Denver CPCRA / Denver Public Hlth Denver Colorado 80204
Wilmington Hosp / Med Ctr of Delaware Wilmington Delaware 19899
Veterans Administration Med Ctr / Regional AIDS Program Washington D.C. District of Columbia 20422
AIDS Research Consortium of Atlanta Atlanta Georgia 30308
AIDS Research Alliance - Chicago Chicago Illinois 60657
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med New Orleans Louisiana 70112
Comprehensive AIDS Alliance of Detroit Detroit Michigan 48201
Henry Ford Hosp Detroit Michigan 48202
Schering - Plough Corp Kenilworth New Jersey 07033
North Jersey Community Research Initiative Newark New Jersey 07103
Addiction Research and Treatment Corp Brooklyn New York 11201
Clinical Directors Network of Region II New York New York 10011
Harlem AIDS Treatment Group / Harlem Hosp Ctr New York New York 10037
Bronx Lebanon Hosp Ctr The Bronx New York 10456
Portland Veterans Adm Med Ctr / Rsch & Education Grp Portland Oregon 97210
Richmond AIDS Consortium Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001034 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →